NASDAQ:CTHR

Charles & Colvard, Ltd. (CTHR) Stock Price, News & Analysis

$0.29
-0.01 (-3.38%)
(As of 05/10/2024 ET)
Today's Range
$0.29
$0.30
50-Day Range
$0.29
$0.39
52-Week Range
$0.28
$0.99
Volume
70,692 shs
Average Volume
125,858 shs
Market Capitalization
$8.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Charles & Colvard, Ltd. MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.10% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.81mentions of Charles & Colvard, Ltd. in the last 14 days
Based on 5 Articles This Week
Insider Trading
Acquiring Shares
$47,311 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.90 out of 5 stars

CTHR stock logo

About Charles & Colvard, Ltd. Stock (NASDAQ:CTHR)

Charles & Colvard, Ltd. operates as a fine jewelry company in the United States and internationally. The company operates in two segments, Online Channels and Traditional. It manufactures, markets, and distributes moissanite jewels and finished moissanite jewelry under the Charles & Colvard Created Moissanite brand; and premium moissanite gemstones under the Forever One brand name. The company also markets and distributes lab grown diamonds and finished jewelry with lab grown diamonds under the Caydia brand. It sells its products at wholesale prices to distributors, manufacturers, retailers, and designers; and to end-consumers at retail prices through charlesandcolvard.com and moissaniteoutlet.com, third-party online marketplaces, drop-ship, and other e-commerce outlets, as well as through Charles & Colvard Signature Showroom and charlesandcolvarddirect.com for wholesale and retail customers. Charles & Colvard, Ltd. was incorporated in 1995 and is headquartered in Morrisville, North Carolina.

CTHR Stock Price History

CTHR Stock News Headlines

The only AI company you should be looking at
This is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse.
Q3 2024 Charles & Colvard Ltd Earnings Call
The only AI company you should be looking at
This is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse.
Charles & Colvard, Ltd. (CTHR)
Q2 2024 Charles & Colvard Ltd Earnings Call
Charles Robinson - Yahoo Sports
See More Headlines
Receive CTHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Charles & Colvard, Ltd. and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/13/2024
Today
5/12/2024
Fiscal Year End
6/30/2024
Next Earnings (Estimated)
10/10/2024

Industry, Sector and Symbol

Industry
Jewelry, silverware, & plated ware
Sub-Industry
N/A
Current Symbol
NASDAQ:CTHR
Employees
48
Year Founded
N/A

Profitability

Net Income
$-19,580,000.00
Pretax Margin
-77.04%

Debt

Sales & Book Value

Annual Sales
$29.95 million
Book Value
$1.02 per share

Miscellaneous

Free Float
22,880,000
Market Cap
$8.67 million
Optionable
Not Optionable
Beta
0.90
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

CTHR Stock Analysis - Frequently Asked Questions

How have CTHR shares performed in 2024?

Charles & Colvard, Ltd.'s stock was trading at $0.4102 at the start of the year. Since then, CTHR shares have decreased by 30.4% and is now trading at $0.2856.
View the best growth stocks for 2024 here
.

When is Charles & Colvard, Ltd.'s next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 10th 2024.
View our CTHR earnings forecast
.

How were Charles & Colvard, Ltd.'s earnings last quarter?

Charles & Colvard, Ltd. (NASDAQ:CTHR) posted its quarterly earnings data on Tuesday, February, 13th. The company reported ($0.09) EPS for the quarter. The business had revenue of $7.91 million for the quarter. Charles & Colvard, Ltd. had a negative trailing twelve-month return on equity of 51.35% and a negative net margin of 77.23%.

What other stocks do shareholders of Charles & Colvard, Ltd. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Charles & Colvard, Ltd. investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Golar LNG Partners (GMLP), Novan (NOVN), Organigram (OGI), Pennsylvania Real Estate Investment Trust (PEI), Bionano Genomics (BNGO), Zosano Pharma (ZSAN) and Aeterna Zentaris (AEZS).

Who are Charles & Colvard, Ltd.'s major shareholders?

Charles & Colvard, Ltd.'s stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Acadian Asset Management LLC (0.86%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Clint J Pete, Don O'connell, Neal I Goldman and Ollin B Sykes.
View institutional ownership trends
.

How do I buy shares of Charles & Colvard, Ltd.?

Shares of CTHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CTHR) was last updated on 5/12/2024 by MarketBeat.com Staff

From Our Partners